NCT06042738 is a NA clinical trial of proxeed plus in Male Infertility, sponsored by Ondokuz Mayıs University.

Who is sponsoring NCT06042738?

NCT06042738 is sponsored by Ondokuz Mayıs University.

What drugs are being tested in NCT06042738?

Interventions in NCT06042738: proxeed plus.

What condition does NCT06042738 study?

NCT06042738 studies Male Infertility.

Is NCT06042738 still recruiting?

NCT06042738 is currently completed. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06042738

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of The Effectiveness of Antioxidant Therapy in Oligoasthenoteratozoospermic Infertile Men

Completed NA Last updated 21 September 2023

What this trial tests

NA trial testing proxeed plus in Male Infertility in 48 participants. Completed in 1 November 2021.

Timeline

1 March 2021

Primary endpoint
1 November 2021

1 November 2021

Quick facts

Lead sponsor	Ondokuz Mayıs University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	48
Start date	1 March 2021
Primary completion	1 November 2021
Estimated completion	1 November 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

proxeed plus

Conditions studied

Male Infertility — all drugs for Male Infertility →

Sponsor

Ondokuz Mayıs University

Who can join

Adults 18 to 60, male only, with Male Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Approximately 30% of the factors that cause male infertility are due to idiopathic causes. Increased reactive oxygen species (ROS) due to many known and unknown factors cause male infertility by affecting spermatogenesis and sperm maturation. In this study, the effects of physical activity and antioxidant food supplementation on seminal antioxidant capacity, sperm DNA fragmentation index, sperm chromatin quality and sperm parameters were investigated in infertile cases.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The impact of antioxidants on antioxidant capacity, DNA fragmentation, and chromatin quality in subfertile men: a randomized clinical trial study.
Sengul M, Sengul M, Hekim N, Asci R, et al · · 2024 · cited 3× · PMID 39536246 · DOI 10.1590/1806-9282.20240211

Verify or expand the search:

Other recruiting trials for Male Infertility

Currently open trials in the same condition.

NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT06956287 — The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility · NA · recruiting
NCT06561451 — Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia · NA · recruiting
NCT07056400 — Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles · NA · active not recruiting

Other Ondokuz Mayıs University trials

Trials by the same sponsor.

NCT07500389 — Postural Habits, Body Awareness, and Functional Performance Across BMI Categories in Women · not yet recruiting
NCT07535242 — Serum GFAP, NfL, VEGF and Clinical Progression in Progressive MS · not yet recruiting
NCT07504848 — Stroke Mobility and Caregiver Outcomes · not yet recruiting
NCT07525557 — Kinesiophobia, Pain and Disability in Chronic Neck Pain · recruiting
NCT07497802 — Mindfulness-Based Psychoeducation for Women With Gynecological Cancer · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06042738 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ondokuz Mayıs University
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06042738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing